
CAS 916599-27-4
:Metabolita M5 di Prasugrel
- R-106583 (Prasugrel Metabolite)
- 2-[1-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-(Methylthio)-3-piperidinylidene]acetic Acid
- Prasugrel Metabolite M5 (R106583)
- Prasugrel metabolite R-106583 (mixture of diastereoisomer)
- Prasugrel Inactive Metabolite R106583 (Mixture of Diastereomers)
- Prasugrel metabolite R106583 hydrochloride salt (Mixture of diastereoisomers)
- (2Z)-2-[1-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-methylsulfanylpiperidin-3-ylidene]acetic acid
- Prasugrel Metabolite M5
- Prasugrel Metabolite (R-106583, Mixture of Diastereomers)
- R 106583
- Prasugrel Metabolite (R-106583)
- Prasugrel Impurity N
- Vedi altri sinonimi
Ref: 4Z-P-3951
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaPrasugrel Metabolite (R-106583, Mixture of Diastereomers)
CAS:Formula:C19H22FNO3SPeso molecolare:363.45Ref: 4Z-P-3959
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaR-106583 (Prasugrel Metabolite)
CAS:Prodotto controllatoFormula:C19H22FNO3SColore e forma:NeatPeso molecolare:363.4462-[1-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-(methylthio)-3-piperidinylidene]acetic acid
CAS:2-[1-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-(methylthio)-3-piperidinylidene]acetic acid is an inhibitor of protein kinases that has shown promising results in the treatment of cancer. This compound has been found to induce apoptosis, or programmed cell death, in cancer cells by targeting specific kinases involved in tumor growth and survival. Additionally, studies have shown that 2-[1-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-(methylthio)-3-piperidinylidene]acetic acid can inhibit the growth of tumors in human models. This compound can be detected in urine samples after administration, and its absorption can be enhanced by co-administration with D-xylose. Overall, this anticancer agent shows great potential for the development of novel cancer therapies.
Formula:C19H22FNO3SPurezza:Min. 95%Peso molecolare:363.4 g/molRef: ST-EA-CP-P27040
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta



